|Net Assets||1.34 Bil|
- Last NAV update 12/11/2013 4:00 PM ET
|The investment seeks capital appreciation. The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.|
- Year to date performance as of 12/10/2013 12:00 AM ET
|Fund Family||Fidelity Investments|
|Fund Manager||Asher Anolic|
|Minimum Initial Purchase||2,500.00|
|Minimum IRA Investment||200.00|
- * Annualized returns
- Performance as of 12/10/2013 12:00 AM ET
|Net Assets||1.34 Bil||693.18 Mil|
|Avg Market Cap||49.59 Bil||24.01 Bil|
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.